Skip to main content
Clinical Trials/TCTR20230502002
TCTR20230502002
Not yet recruiting
Phase 3

Prospective Randomized Controlled Trial to evaluate effectiveness of adjuvant Silodosin for Improving the Stone-Free Rate after Extracorporeal Shock Wave Lithotripsy in Renal Stones

Rayong Hospital0 sites100 target enrollmentMay 2, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Stone free status
Sponsor
Rayong Hospital
Enrollment
100
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 2, 2023
End Date
May 16, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rayong Hospital

Eligibility Criteria

Inclusion Criteria

  • Renal stone patient

Exclusion Criteria

  • on anticoagulant

Outcomes

Primary Outcomes

Not specified

Similar Trials